These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Emerging issues with bisphosphonates.
    Author: Reid IR.
    Journal: Rheum Dis Clin North Am; 2006 Nov; 32(4):691-702, vi. PubMed ID: 17288972.
    Abstract:
    Bisphosphonates are the most commonly used agents in the management of metabolic bones diseases. Despite their established therapeutic value, a number of points of uncertainty remain, particularly in connection with their optimal long-term use. It is likely that definitive clinical trial data will not become available to resolve these questions, so careful clinical observation and caution are needed in patients who require treatment over periods of more than 10 years.
    [Abstract] [Full Text] [Related] [New Search]